Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

Heart. 2000 Oct;84(4):438-9. doi: 10.1136/heart.84.4.438.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adult
  • Apoptosis / drug effects
  • Biomarkers / blood
  • Cardiomyopathy, Dilated / blood*
  • Cardiomyopathy, Dilated / drug therapy
  • Case-Control Studies
  • Double-Blind Method
  • Humans
  • Middle Aged
  • Pentoxifylline / therapeutic use*
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / analysis
  • Ventricular Dysfunction, Left / blood*
  • fas Receptor / blood*

Substances

  • Biomarkers
  • Phosphodiesterase Inhibitors
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • Pentoxifylline